Overview:
Digital pathology refers to use of digital tools and solutions for automation of pathology processes and lab testing. Growing prevalence of cancer and chronic diseases, increasing demand for rapid pathological tests and automation of healthcare system are some of the major factors that facilitated the advent of digital pathology. Digital pathology conveniently improves workflow efficiency and deliver faster and accurate test results as against the conventional methods. Other factors that are driving the growth of digital pathology market are ease of reach to remote areas, efficient record-keeping and reduction in diagnosis cost.
Technologies such as while slide imaging finds widest application in pharmaceutical research. High-resolution sample scanning, cloud storage of diagnostics data, ease of interpretation of voluminous data and data sharing are some of the prime features that has led to rapid adoption of digital pathology in pharmaceuticals sector. Though the concept of digital pathology is known for over a decade, it has only recently received its fair share of fame attributed by the latest technological advancements and its capability in cost containment in long-term application. High prevalence of cancer and the resultant urgency in rapid screening and diagnosis to deliver better treatment outcomes is also a significant factor that has urged the growth in demand for digital pathology in the field of disease diagnosis.
The global digital pathology systems market is segmented on the following bases:
1. Technology
a. Whole Slide Imaging
b. Image Analysis-Informatics
c. Storage, Communication And Integrated Platforms
2. Products
a. Scanners
b. Software
c. Communication Systems
d. Storage Systems
3. End-Use
a. Disease Diagnosis
b. Academics and Research
c. Drug Discovery and Development
4. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for digital pathology market include but are not limited to:
Leica Biosystems, Philips Healthcare, Ventana Medical Systems, Inc., Visiopharm A/S, Omnyx, LLC,Hamamatsu Photonics Inc., Definiens, 3DHISTECH Ltd., Nikon Instrumentsand several others
This report offers:
- An overview of the global markets for digital pathology solutions
- Market trends assessment for the period 2014-2022, with historical information for 2014 & 2015, and projections through 2022, with respective CAGRS during 2016-2022
- Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
- Market competition scrutiny tools such as market share analysis, attractive investment proposition, and Porter’s Five Forces model
- Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics
- A general overview of the industry structure
- Company profiles highlighting key information about the major players operating in the digital pathology market
